mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation
The anti-inflammatory cytokine Interleukin-10 (IL-10) is considered an efficient treatment for corneal inflammation, in spite of its short half-life and poor eye bioavailability. In the present work, mRNA-based nanomedicinal products based on solid lipid nanoparticles (SLNs) were developed in order...
Main Authors: | Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Sara Garelli, Luigi Battaglia, Ana del Pozo-Rodríguez, María Ángeles Solinís |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/9/1472 |
Similar Items
-
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
by: Itziar Gómez-Aguado, et al.
Published: (2020-02-01) -
Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production
by: Mónica Vicente-Pascual, et al.
Published: (2020-06-01) -
MMP-9 Downregulation with Lipid Nanoparticles for Inhibiting Corneal Neovascularization by Gene Silencing
by: Josune Torrecilla, et al.
Published: (2019-04-01) -
Complete depigmentation of a small aperture corneal inlay implanted for compensation of presbyopia
by: Mauro Campos, et al. -
Nanomedicine Approaches for Corneal Diseases
by: Shyam S. Chaurasia, et al.
Published: (2015-04-01)